WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014190860) HUMAN SOURCE EGF STRUCTURAL DOMAIN PROTEIN AND APPLICATION OF SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/190860    International Application No.:    PCT/CN2014/077789
Publication Date: 04.12.2014 International Filing Date: 19.05.2014
IPC:
C07K 14/745 (2006.01), A61K 38/36 (2006.01), A61P 31/04 (2006.01)
Applicants: CHENGDU SOURCEBIO LIMITED-LIABILITY COMPANY [CN/CN]; Floor 2, Astatech Building, No.9-1 South Keyuan Road, High-Tech Zone Chengdu, Sichuan 610041 (CN)
Inventors: SONG, Xu; (CN).
LI, Ling; (CN).
CHEN, JinWu; (CN).
MA, Deng Jiao; (CN)
Agent: BOSS & YOUNG PATENT AND TRADEMARK LAW OFFICE; 5/F., Tower A, GT International Center, Jia 3 Yongandongli Jianguomenwai Ave., Chaoyang District Beijing 100022 (CN)
Priority Data:
201310206726.6 29.05.2013 CN
201410182727.6 30.04.2014 CN
Title (EN) HUMAN SOURCE EGF STRUCTURAL DOMAIN PROTEIN AND APPLICATION OF SAME
(FR) DOMAINE STRUCTURAL PROTÉIQUE DE TYPE EGF D'ORIGINE HUMAINE ET SON UTILISATION
(ZH) 人源EGF结构域蛋白及其应用
Abstract: front page image
(EN)Disclosed is a human source EGF structural domain protein. The amino-acid sequence of the protein is represented by SEQ ID NO:1, or has a sequence similarity above 50% to the sequence represented in SEQ ID NO:1. The human source EGF structural domain protein can be used for treating gram-negative bacteria infection and endotoxemia.
(FR)La présente invention concerne un domaine structural protéique de type EGF d'origine humaine. La séquence d'acides aminés dudit domaine structural protéique est représentée par SEQ ID NO : 1, ou présente une similarité de séquence supérieure à 50 % avec la séquence représentée par SEQ ID NO : 1. Ledit domaine structural protéique de type EGF d'origine humaine peut être utilisé pour traiter les infections par les bactéries Gram négatif et l'endotoxémie.
(ZH)公开了人源EGF结构域蛋白,所述蛋白的氨基酸序列如SEQ ID NO:1所示,或与SEQ ID NO:1所示的序列具有50%以上同源性。所述人源EGF结构域蛋白能用于治疗革兰氏阴性菌感染及内毒素血症。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)